Drug Profile
Pneumococcal conjugate vaccine - PnuVax
Alternative Names: PCV-13Latest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator PnuVax
- Class Conjugate vaccines; Pneumococcal vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Pneumococcal-infections in Canada
- 02 Oct 2017 Preclinical trials in Pneumococcal infections in Canada (unspecified route)